Mar 28, 2024 04:32PM
Jan 27, 2021 08:34AM
Jan 27, 2021 08:30AM
Jan 25, 2021 07:38AM
Jan 14, 2021 07:30AM
Jan 13, 2021 07:30AM
Dec 22, 2020 07:30AM KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder
Dec 2, 2020 07:30AM
Nov 23, 2020 04:30PM
Nov 18, 2020 08:30AM
Oct 29, 2020 04:05PM
Oct 22, 2020 07:30AM
Oct 5, 2020 08:46AM
Sep 25, 2020 05:00PM KemPharm Files Preliminary Proxy for Special Meeting of Stockholders
Sep 2, 2020 04:05PM
Aug 14, 2020 07:30AM
Aug 12, 2020 04:05PM
Jul 28, 2020 07:30AM
Jun 18, 2020 08:30AM
May 19, 2020 07:32AM
May 19, 2020 07:30AM KemPharm Receives Day-74 Letter for KP415 NDA
May 12, 2020 04:05PM
May 4, 2020 08:05AM
May 4, 2020 08:00AM
Mar 2, 2020 04:47PM
Mar 2, 2020 04:18PM
Feb 28, 2019 04:05PM
Nov 9, 2017 04:05PM KemPharm Reports Third Quarter 2017 Results and Provides Corporate Update
Sep 12, 2017 07:17AM
Sep 12, 2017 07:15AM
Aug 10, 2016 07:00AM
Jun 14, 2016 10:41AM
Jun 9, 2016 06:56AM
Jun 9, 2016 06:55AM
May 6, 2016 06:45AM Kempharm (KMPH) PT Lowered to $14 at RBC Following FDA Panel Vote
May 5, 2016 05:17PM
May 5, 2016 05:16PM
May 5, 2016 07:31AM
May 5, 2016 07:30AM
Mar 24, 2016 09:10AM
Mar 24, 2016 09:09AM
Mar 14, 2016 09:59AM KemPharm (KMPH) Announces FDA Committee Meeting Date to Review KP201/APAP NDA
Mar 14, 2016 09:58AM
Mar 10, 2016 03:49PM
Feb 19, 2016 07:30AM
Feb 10, 2016 07:32AM
Feb 10, 2016 07:30AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All